We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · February 17, 2021

Tumor Tissue– vs Plasma-Based Genotyping for Selection of Matched Therapy and Impact on Outcomes in Patients With Metastatic Breast Cancer

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Tumor Tissue- Versus Plasma-Based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients With Metastatic Breast Cancer
Clin. Cancer Res 2021 Jan 27;[EPub Ahead of Print], N Vidula, A Niemierko, G Malvarosa, M Yuen, JK Lennerz, AJ Iafrate, SA Wander, LM Spring, D Juric, SJ Isakoff, J Younger, B Moy, LW Ellisen, A Bardia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading